RK

Rintu Kumar Das

Active Director Director DIN 10690895
DIN 10690895 First appointment Jul 2024 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Rintu Kumar Das

Data last updated:

Rintu Kumar Das is a Director at Grandcity International Hospital And Research Centre Private Limited (since 2024). The company operates in Healthcare.

DIN 10690895
Primary Designation Director
Industry Healthcare
First Appointment 01 Jul 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Jul 20242024Active

Directorship timeline

Open interactive timeline →
Grandcity International Hospital And Research Centre Private Limited
Premium access

Shareholding and investment profile for Rintu Kumar Das

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rintu Kumar Das

Rintu Kumar Das currently holds 1 directorship: Grandcity International Hospital And Research Centre Private Limited (Director, since 01 Jul 2024).

Rintu Kumar Das was first appointed on 01 Jul 2024 as Director at Grandcity International Hospital And Research Centre Private Limited.

The current boards of Rintu Kumar Das's companies include Pradip Kumar Saha (Grandcity International Hospital And Research Centre Private Limited), Pulin Kumar Das (Grandcity International Hospital And Research Centre Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available